Details of the Drug Formulations

General Information of Drug (ID: DM5A31S)

• Drug Name: TP-434 Drug Info
• Synonyms: TP-038; TP-120; TP-170; TP-221; TP-271; TP-787; Tetracycline analogs (bacterial infection), Tetraphase Pharmaceuticals; Tetracycline derivatives (bacterial infection), Tetraphase Pharmaceuticals; Fluorocycline antibiotic (oral, bacterial infection), Tetraphase Pharmaceuticals; Tetracycline analogs (iv, antibiotic), Tetraphase Pharmaceuticals; TP-434 (oral, multidrug-resistant bacterial infections); TP-434 (oral, multidrug-resistant bacterial infections), Tetraphase Pharmaceuticals

Indication

Disease Entry	ICD 11	Status	REF
Intra-abdominal infection	1A40	Approved	[1]
Influenza virus infection	1E30-1E32	Phase 2	[2]

• Cross-matching ID:
  PubChem CID: 54726192
  CAS Number: 1207283-85-9
  TTD ID: D0LZ7E
  INTEDE ID: DR2504
  ACDINA ID: D01056

Full List of Drug Formulations Containing This Drug

Eravacycline 50 mg For Injection

Company	Formulation ID	FDA Description
Tetraphase Pharmaceuticals	F23157	Mannitol; Sodium Hydroxide; Hydrochloric Acid

References

• [1] The antibiotic arms race: current and emerging therapy for Klebsiella pneumoniae carbapenemase (KPC) - producing bacteria.Expert Opin Pharmacother. 2018 Oct 22:1-13.
• [2] ClinicalTrials.gov (NCT01265784) Study to Compare TP-434 and Ertapenem in CA Complicated Intra-abdominal Infections. U.S. National Institutes of Health.